Monogenic Screening (11+ Types)

(HG-PMS-11+ )

HK $4, 800

In addition to general interested individuals, screening is also suitable for:

✔️ Couples planning for family planning
✔️ Reproductive-age couples with a family history of disease
✔️ Couples preparing for assisted reproductive technologies
✔️ Couples in consanguineous marriages

Advantages of the Testing

• Comprehensive – The testing covers a wide range, including two types of mutations.
• Cost-effective – More economical compared to testing for individual genetic disorders.
• Simple – Requires only a 5ml peripheral blood sample.
• Professional – Supported by a comprehensive disease database and specialized genetic testing services.

Why choose Monogenic Screening?

Since most people are unaware of being carriers of genetic diseases, individuals with recessive genetic diseases often show no symptoms. Routine prenatal tests also cannot detect abnormalities, leading to the discovery of such conditions only when symptoms appear in the child after birth. Therefore, the “Monogenic Screening (11+ Types)” can screen for 11+ hereditary diseases caused by over 5,400 mutation variants. Compared to testing for a single genetic disease, the “ Monogenic Screening Test (11+ Types)” is more cost-effective and comprehensive.

Why Early Testing is Crucially Important?

For individuals with a family history of genetic diseases:

1.  Risk Assessment and Management:  For individuals with a family history of genetic diseases, undergoing “Monogenic Screening” helps in early detection of genetic disorders and assessing the risk of developing certain hereditary conditions. This enables them to make lifestyle adjustments as needed or undergo preventive screening.
2. Family Planning: For individuals planning to expand their families, understanding their genetic risk can influence their reproductive decisions and prompt them to consider other options, such as surrogacy or genetic assisted technologies.

For couples planning to have a baby:

1. Genetic Risk Assistance: For couples planning pregnancy, early testing can screen for any potential genetic disease risks, enabling them to make informed choices.

2. Reproductive Decision Support: The test results can provide couples with information about pregnancy risks and options, allowing them to jointly decide on the most suitable reproductive plan, thereby reducing the risk of potential hereditary diseases in the future.

What are monogenic disease?

Accoding to the World Health Organisation (WHO):

• Monogenic diseases result from modification in a single gene occurring in all cells of the body.
• Scientists currently estimate that over 10,000 of human diseases are known to be monogenic.
• Monogenic diseases are responsible for a heavy loss of life. The global prevalence of all single gene diseases at birth is approximately 10/10000.

Booking Procedure

For more details on the program, please click check-up items.